Insider Transactions in Q4 2024 at Lumos Pharma, Inc. (LUMO)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2024
|
Joseph S Mc Cracken Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,721
-100.0%
|
-
|
|
Dec 12
2024
|
Lori D Lawley Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,284
-100.0%
|
-
|
|
Dec 12
2024
|
Bradley J Powers General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
27
-100.0%
|
-
|
|
Dec 12
2024
|
Bradley J Powers General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,307
-100.0%
|
-
|
|
Dec 12
2024
|
Aaron Schuchart Chief Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,179
-100.0%
|
-
|
|
Dec 12
2024
|
Kevin M. Lalande Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
730,446
-100.0%
|
-
|
|
Dec 12
2024
|
Kevin M. Lalande Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,076
-100.0%
|
-
|
|
Dec 12
2024
|
Pisit Duke Pitukcheewanont Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,836
-100.0%
|
-
|
|
Dec 12
2024
|
Thomas A. Raffin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,406
-100.0%
|
-
|
|
Dec 12
2024
|
An Van Es Johansson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,100
-100.0%
|
-
|
|
Dec 12
2024
|
Chad Allen Johnson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,076
-100.0%
|
-
|
|
Dec 12
2024
|
John C. Mc Kew Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,153
-100.0%
|
-
|
|
Dec 12
2024
|
Lota S. Zoth Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,187
-100.0%
|
-
|
|
Dec 12
2024
|
Richard J Hawkins Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,469
-100.0%
|
-
|
|
Dec 12
2024
|
Richard J Hawkins Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
753,093
-100.0%
|
-
|